Prospect Capital Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SMLR
Semler Scientific
SMLR
|
+$25.2M |
| 2 |
Destination XL Group
DXLG
|
+$5.69M |
| 3 |
SkinHealth Systems
SKIN
|
+$5.63M |
| 4 |
Silicon Motion
SIMO
|
+$3.87M |
| 5 |
Dave & Buster's
PLAY
|
+$3.71M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
InMode
INMD
|
+$5.3M |
| 2 |
eHealth
EHTH
|
+$4.49M |
| 3 |
Builders FirstSource
BLDR
|
+$4.37M |
| 4 |
OptimizeRx
OPRX
|
+$4.05M |
| 5 |
Organogenesis Holdings
ORGO
|
+$2.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 26.75% |
| 2 | Healthcare | 19.35% |
| 3 | Technology | 17.76% |
| 4 | Consumer Staples | 10.2% |
| 5 | Industrials | 6.69% |
Similar funds
Prospect Capital Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, Prospect Capital Advisors held 39 positions worth $303M, up 13% from $269M the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Prospect Capital Advisors deployed $36.4M of net new capital in Q3 2021, opening 6 new positions and adding to 12 existing holdings. Its largest new stake was Semler Scientific: 199,810 shares worth $25M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 27% of assets, down from 29% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was InMode, an estimated $5.3M trimmed.
- Prospect Capital Advisors's largest Q3 2021 buy was Semler Scientific: 199,810 shares worth $25M.
- Prospect Capital Advisors added most to Silicon Motion in Q3 2021, an estimated $3.87M increase.
- Prospect Capital Advisors's biggest Q3 2021 reduction was InMode, cutting an estimated $5.3M.
- Prospect Capital Advisors fully exited eHealth in Q3 2021, selling an estimated $4.49M.
- Prospect Capital Advisors's ten largest holdings make up 64% of its $303M portfolio in Q3 2021.
- Prospect Capital Advisors opened 6 new positions and closed 5 in Q3 2021.
- Prospect Capital Advisors's portfolio value rose 13% quarter-over-quarter to $303M.
Based on Prospect Capital Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.